Kinvestor
News
Markets
Earnings
Insider
Portfolio
Pricing
Get Started
ALLO
Allogene Therapeutics Inc
Biotechnology
+ Watchlist
View SEC Filings
Overview
Financials
Earnings
Insider
Ownership
Filings
News
Allogene Therapeutics Inc (ALLO) Earnings
Last reported
May 13, 2026
EPS estimate
-$0.19
EPS actual
—
Revenue est.
$2.0K
Revenue actual
—
Related:
ALLO overview
·
ALLO financials
·
ALLO news